The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
about
Topical n -docosanol for management of recurrent herpes labialisInterventions for treatment of herpes simplex labialis (cold sores on the lips)The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia.Efficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic reviewTreatment of experimental herpesvirus infections with phosphonoformate and some comparisons with phosphonoacetateHerpes simplex infections.Ocular shedding of herpes simplex virus.Prospects for control of herpes simplex virus disease through immunization.Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer.Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial. The Penciclovir Immunocompromised Study Group.Clinical and virologic course of herpes simplex genitalis.Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy: a clinical protocol with 3-year follow-up.Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.Chemotherapy for herpes simplex virus infectionsEvolution of recurrent herpes simplex lesions. An immunohistologic study.Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyOral acyclovir for genital herpes: not a cure, but close.Clinical manifestations and treatment considerations of herpes simplex virus infection.Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir.A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeDermacase. Herpes simplex virus.Current management and recommendations for access to antiviral therapy of herpes labialisTopical Acyclovir for Recurrent Herpes Labialis in Primary Care: Critical appraisalTherapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.Iontophoretic application of adenine arabinoside monophosphate to herpes simplex virus type 1-infected hairless mouse skinTreatment of recurrent herpes simplex labialis with levamisole.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesisRapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tractZosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent diseaseRole of antibody in primary and recurrent herpes simplex virus infection.Herpes simplex virus antigen direct detection in standard virus transport medium by Du Pont Herpchek enzyme-linked immunosorbent assay.Comparison of the detection of herpes simplex virus in direct clinical specimens with herpes simplex virus-specific DNA probes and monoclonal antibodies.Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity.Identification and typing of herpes simplex viruses with monoclonal antibodies.Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection.Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.Acyclovir Lauriad(®): a muco-adhesive buccal tablet for the treatment of recurrent herpes labialis.Pathogenesis and immunobiology of herpes simplex virus in mouse and man.
P2860
Q22306022-2675C50C-0EF4-4DD4-8D74-C7231626CF25Q24236514-830D5D47-DFEC-499F-9D40-7BD5AC873EB0Q24523533-C46BD6E9-D417-4CB7-9F1F-7A831C2AE673Q26849607-22BBACA8-E045-454F-B41B-2F337C7A36C2Q28322290-1CF96499-23EA-4457-8EE9-0044382E9459Q33580314-8C2B661F-95F0-44EA-B804-9F951AB977B3Q33647773-944D991A-B5AC-446C-8988-BE15996AB774Q33866424-44931FBE-D8B2-49A4-B505-A9F5F16265D3Q33912259-08FB7BFB-5B55-4E5D-9CAC-2CD2F84DF9FAQ33976296-6520C43D-628C-4266-A3BF-D2455ED99AFEQ34052511-8587CC38-2C57-403D-BFE7-E5FDB052D924Q34075252-798B1FAA-705E-4F87-8C33-91F5AD58C6C1Q34101028-AF07F589-BE53-4961-8923-0D22F8259799Q34193041-BEE844D2-DF75-4B8A-AD3D-D1C73C0247D3Q34524213-639750E8-BD6B-4B71-A030-FF5A706858B0Q34566092-9EF1F574-31CD-4C68-8D98-F4B5875CDAD5Q34579981-FCE4D4CE-E352-4117-B328-8E1689AF151FQ34730888-DA0A3E28-A56E-4E6D-8A35-BA70A6D27077Q34918343-A3F97CDB-0B6F-4CAE-82A1-8141D2A9043EQ35759608-6EFA359B-AD39-4DDB-B4C3-1D7BD08C3211Q35871689-DF06A82D-A058-4418-BCA5-42DB24724679Q36059130-BD4CE8B9-6F2B-4B78-8192-D7291174835BQ36178308-A120BD5E-46FB-48A4-AC4F-9BA6B93EED92Q36282949-FEA83705-3C46-48A9-A0F2-ADB64A897857Q36473887-803EDFF1-BE28-472D-AC05-6770211E4DD4Q36474933-A8D24DA9-7ABF-43DC-B3C7-D88F802E6BB2Q36480586-9ED63CF2-66A1-4A7A-884C-BC60BB6369BFQ36555158-6E6EFF0F-A695-41DE-9766-B203B7C16C7BQ36607105-9608059A-2EA8-45D4-A7C8-94A980858987Q36776541-3F4C224F-61F9-472D-9A70-927F092708FEQ36896514-D5D3C356-B591-4432-AF26-DD6D4DAC38E6Q36899596-115503D4-9E7F-40D4-8D7E-38BA9B9D5A8CQ37192610-B8FBD37B-C028-48A5-80A1-4448B14CA23AQ37199777-84623BC9-E883-45DD-8DEB-80B77F2424D1Q37263886-EBDB974D-BCE7-4DF1-B511-34A73170563FQ37295723-45B82F94-066A-49A8-9E63-352ED82670EFQ37336031-E6CC48CB-2F9E-4E55-B81A-0F798F2EDF19Q37643645-C4ADC1F8-A27E-4A9B-B684-9C23CB43E295Q38181219-853AB063-9837-42AC-BC44-2FCC87276328Q39614014-C9A9F8F8-56D4-4AA2-96FB-0A97FED4BCD0
P2860
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
The natural history of recurre ...... cations for antiviral therapy.
@en
type
label
The natural history of recurre ...... cations for antiviral therapy.
@en
prefLabel
The natural history of recurre ...... cations for antiviral therapy.
@en
P2093
P1476
The natural history of recurre ...... cations for antiviral therapy.
@en
P2093
P356
10.1056/NEJM197707142970201
P407
P577
1977-07-01T00:00:00Z